Research Progress on the Mechanisms of Combined Bevacizumab and Radiotherapy

ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)


Volume 9, 3 Issues, 2014


Download PDF Flyer




Recent Patents on Anti-Cancer Drug Discovery

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 96th of 261 in Pharmacology & Pharmacy
  • 92nd of 197 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Khurshid Zaman
Bentham Science Publishers
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.7
5 - Year: 2.475

Research Progress on the Mechanisms of Combined Bevacizumab and Radiotherapy

Author(s): Hong-Qing Zhuang, Zhi-Yong Yuan and Ping Wang

Affiliation: Department of Radiotherapy, Tianjin Cancer Institute and Hospital, Tianjin, P.R. China.

Abstract

Bevacizumab, one of the best-known patents of VEGF inhibitor, has demonstrated significant radiosensitive effects on various preclinical tumor models and clinical trials recently. The radiosensitive effects of this novel patent have achieved satisfactory efficacy through the following mechanisms: normalization of the tumor vasculature, overcoming resistance to radiation, inhibition of repopulation after radiation, and blockade of radiation-induced increased VEGF expression. The combination of bevacizumab with radiotherapy in the treatment of malignant tumors was an inevitable path for the further clinical development of bevacizumab and a very good opportunity for improving the curative effect of radiotherapy. However, many questions such as those regarding the bevacizumab administration dosage and schedule, radio sensitivity efficacy evaluation and multi-target radiosensitive therapy need further research. The advent of bevacizumab combined with radiation has left physicians to encounter multiple challenges as well as opportunities for improving anti-cancer drug treatments.

Keywords: Angiogenesis, anti-angiogenic therapies, bevacizumab, radiotherapy, radiosensitivity.

Download Free Rights and Permissions

Article Details

Volume: 9
Issue Number: 1
First Page: 129
Last Page: 134
Page Count: 6
DOI: 10.2174/15748928113089990044
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science